2.1 100 mg/kg x 5 days vs 200 mg/kg x 5 days |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.1.1 All coronary artery abnormalities ‐ 0‐30 days |
2 |
162 |
Risk Ratio (M‐H, Random, 95% CI) |
1.76 [1.07, 2.89] |
2.2 100 mg/kg x 5 days vs 400 mg/kg x 5 days |
3 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.2.1 All coronary artery abnormalities ‐ 0‐30 days |
3 |
401 |
Risk Ratio (M‐H, Random, 95% CI) |
2.79 [1.59, 4.91] |
2.2.2 All coronary artery abnormalities ‐ 31‐60 days |
2 |
333 |
Risk Ratio (M‐H, Random, 95% CI) |
3.14 [1.38, 7.15] |
2.3 200 mg/kg x 5 days vs 400 mg/kg x 5 days |
4 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.3.1 All coronary artery abnormalities ‐ 0‐30 days |
4 |
623 |
Risk Ratio (M‐H, Random, 95% CI) |
2.44 [1.49, 4.00] |
2.4 400 mg/kg x 5 days vs 2 gm/kg single dose |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.4.1 All coronary artery abnormalities ‐ 0‐30 days |
2 |
253 |
Risk Ratio (M‐H, Random, 95% CI) |
4.47 [1.55, 12.86] |
2.5 Fever 200 mg/kg x 3 days vs 400 mg/kg/day x 3 days |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |